Her2 Chimeric Antigen Receptor Expressing T Cells in Advanced Sarcoma

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Her2 Chimeric Antigen Receptor Expressing T Cells in Advanced Sarcoma	Neoplasms by Histologic Type, Neoplasms, Connective and Soft Tissue, neoplasm, sarcoma	Active, not recruiting	Phase 1	2026-01-26		NCT00902044

4 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Baylor College of Medicine	267
Cancer Prevention Research Institute of Texas	29
Center for Cell and Gene Therapy, Baylor College of Medicine	40
The Methodist Hospital Research Institute	124

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Houston Methodist Hospital	Houston	United States	260
Texas Children's Hospital	Houston	United States	187

Clinical trials